Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights (Q37950427)

25 August 2017

title

Pharmacologic safety concerns in Parkinson's disease: facts and insights (English)

1 reference

25 August 2017

Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights (English)

1 reference

DOI

https://api.crossref.org/works/10.3109/00207454.2011.620193

16 December 2024

1 reference

1 reference

Jack J. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22035029

16 December 2024

language of work or name

1 reference

1 January 2011

1 reference

25 August 2017

2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22035029

full work available at URL

16 December 2024

http://www.tandfonline.com/doi/pdf/10.3109/00207454.2011.620193

1 reference

DOI

https://api.crossref.org/works/10.3109/00207454.2011.620193

International Journal of Neuroscience

16 December 2024

published in

1 reference

25 August 2017

volume

121 Suppl 2

1 reference

25 August 2017

page(s)

45-52

1 reference

A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Tolcapone: an efficacy and safety review (2007)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Tolcapone and hepatotoxic effects. Tasmar Advisory Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Toxicology and Safety of Comt Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serious tolpcapone-induced hepatitis 17 months after commencing treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Excessive Daytime Sleepiness in Patients with Parkinsonʼs Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Excessive daytime sleepiness and unintended sleep in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Dopamine agonists and sleepiness in PD: review of the literature and personal findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Impulse control and related disorders in Parkinson's disease: review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Association of dopamine agonist use with impulse control disorders in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Topiramate in managing impulse control disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Zonisamide in managing impulse control disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Linezolid and serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

An interesting case of serotonin syndrome precipitated by escitalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Dextromethorphan-induced serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

The Libby Zion case. One step forward or two steps backward?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Severe adverse interaction between pethidine and selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin syndrome induced by fluvoxamine and oxycodone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotoninergic antidepressants and opiate analgesics: a sometimes-painful association. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin syndrome precipitated by fentanyl during procedural sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Serotonin toxicity caused by an interaction between fentanyl and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

A possible L-deprenyl induced hypertensive reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.620193

Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients - A double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

Tolcapone and fulminant hepatitis

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

The Emergence of Devastating Impulse Control Disorders During Dopamine Agonist Therapy of the Restless Legs Syndrome

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

Rasagiline‐induced serotonin syndrome

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

16 December 2024

1 reference

https://api.crossref.org/works/10.3109/00207454.2011.620193

16 December 2024

Identifiers

DOI

1 reference

25 August 2017

1 reference